Genetic Technologies Ltd s in-depth stock price analysis indicates that the stock price has dropped -10.79% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -38.92% . Looking at the past 52 week period, the stock price is down -39.81% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Genetic Technologies Ltd has a negative value of -53.25 compared to overall market performance. Genetic Technologies Ltd (NASDAQ:GENE) has climbed 9.73% in the past week and advanced 6.9% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 8.85% and the outperformance has advanced to 4.98% for the last 4 weeks period.
Genetic Technologies Ltd (NASDAQ:GENE) : On Friday heightened volatility was witnessed in Genetic Technologies Ltd (NASDAQ:GENE) which led to swings in the share price. The stock opened for trading at $1.25 and hit $1.38 on the upside , eventually ending the session at $1.24, with a gain of 3.33% or 0.04 points. The heightened volatility saw the trading volume jump to 1,284,003 shares. The 52-week high of the share price is $2.89 and the company has a market cap of $14 million. The 52-week low of the share price is at $1.04 .
Genetic Technologies was the first company in the world to recognize important new applications for non-coding DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.